My guess is they are all working very hard on the uplisting. I suspect there was a strategic intent to have a slew of big things happening at once, and all centered around FDFA approval for our trials. It seems like that "finance exec talk" was more than 2 weeks ago, and they must be 3-4 weeks into the process. I would guess the 6-week process was also a best-case scenario, not unlike the BLA filing where certain details have to be tended to. But whether it's 3 more weeks or 5 or 7, it will happen and be a BIG event. Plus vials of Leronlimab arriving from Samsung, Dr. P's paper, trial results, NASH starting up, cancer trials continuing and updates provided, big investment bank/financing announced.....the price could just continue its great run.
To The Moon Alice